Imagine having a perfect digital copy of a patient's heart and blood vessels before a surgeon ever touches them. This software lets doctors test different stents or valves in a virtual world to see exactly how they will fit and behave. It is like using a flight simulator for heart surgery to avoid mistakes and find the best plan for each person.
Cardiovascular interventions suffer from high complication rates (up to 40%) and a lack of quantitative data for strategy selection. Additionally, medical device manufacturers face excessively long time-to-market due to a lack of simulation tools during design.
A cloud-based software platform called PlanOp that creates 3D digital twins of patient anatomy and implants to simulate surgical procedures.
If you are a device manufacturer dealing with long time-to-market cycles — this project developed in silico clinical trials and numerical simulations that allow for better design and faster validation of future devices.
If you are a hospital dealing with post-operative complication rates up to 40% — this project developed PlanOp software that predicts complications and helps physicians select the best therapeutic strategy before the procedure.
If you are a software provider dealing with a lack of quantitative parameters for treatment selection — this project developed a cloud-based platform using AI and digital twins to provide predictive simulations for endovascular interventions.
Based on available project data, the specific pricing for the PlanOp software is not disclosed, though it is described as a cloud-based platform.
The current focus is on endovascular aortic repair (EVAR) and transcatheter mitral valve repair (TMVr), but the core technology is designed for cardiovascular interventions generally.
PrediSurge holds an exclusive license agreement to use and commercially exploit patented innovative technology for patient-specific numerical simulation from Mines Saint-Etienne.
The platform is cloud-based, allowing physicians to visualize 3D behavior of implants and test strategies days before the actual implantation.
The project period ran from 2022-11-01 to 2024-10-31 to accelerate business development and market leadership.
The project is led by a single SME, PrediSurge, which is a spin-off from Mines Saint-Etienne. With a 100% industry ratio and a €2.5 million EU contribution, the structure is lean and focused entirely on commercialization and business acceleration rather than academic research.
Contact PrediSurge (France) regarding the PlanOp platform
Contact us to find similar AI-driven medical simulation technologies.
